Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Donald D Hoang"'
Autor:
Felix Yang, Susan M. Frayne, Jessica A. Hellyer, Donald D. Hoang, Daniel W. Kaiser, Ciaran S. Phibbs, Paul A. Heidenreich, Claire T. Than, Mintu P. Turakhia, Susan K. Schmitt, Aditya J. Ullal, Wolfgang C. Winkelmayer
Publikováno v:
Heart. 103:818-826
Objective To evaluate warfarin prescription, quality of international normalised ratio (INR) monitoring and of INR control in patients with atrial fibrillation (AF) and chronic kidney disease (CKD). Methods We performed a retrospective cohort study o
Autor:
James V. Freeman, Paul J. Wang, Mintu P. Turakhia, Paul A. Heidenreich, Jared D. Miller, Marco V Perez, Donald D. Hoang, Claire T. Than, Karen Friday, Aditya J. Ullal
Publikováno v:
Clinical Cardiology
Background Identification of silent atrial fibrillation (AF) could prevent stroke and other sequelae. Hypothesis Screening for AF using continuous ambulatory electrocardiographic (ECG) monitoring can detect silent AF in asymptomatic in patients with
Autor:
Claire T. Than, Tyson H. Holmes, Paul A. Heidenreich, Pasquale Santangeli, P. Michael Ho, Wolfgang C. Winkelmayer, Aditya J. Ullal, Susan K. Schmitt, Susan M. Frayne, Ciaran S. Phibbs, Donald D. Hoang, Xiangyan Xu, Mintu P. Turakhia, Felix Yang
Publikováno v:
Journal of the American College of Cardiology. 64(7):660-668
BACKGROUND Despite endorsement of digoxin in clinical practice guidelines, there exist limited data on its safety in atrial fibrillation/flutter (AF). OBJECTIVES The goal of this study was to evaluate the association of digoxin with mortality in AF.
Autor:
Paul A. Heidenreich, Mintu P. Turakhia, Paul J. Wang, Donald D. Hoang, Marco V Perez, Tyson H. Holmes, Alexander C. Perino, Pasquale Santangeli
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 7(5)
Background— The preferential citation of studies with the highest success rates could exaggerate perceived effectiveness, particularly for treatments with widely varying published success rates such as radiofrequency catheter ablation for atrial fi
Autor:
Aditya J Ullal, Donald D Hoang, Claire Than, Paul A Heidenreich, Jared D Miller, Karen Friday, Victor F Froelicher, Mintu P Turakhia
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6
INTRODUCTION: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, accounting for up to one in five strokes. Identification of silent AF could reduce the total burden of stroke, particularly with newer, low-cost noninvasive metho
Autor:
Donald D. Hoang, Xiangyan Xu, Wolfgang C. Winkelmayer, Mintu P. Turakhia, Paul A. Heidenreich, Felix Yang
Publikováno v:
Journal of the American College of Cardiology. 59(13)
Autor:
Aditya J. Ullal, Mintu P. Turakhia, Matthew D. Solomon, Donald D. Hoang, James V. Freeman, Paul A. Heidenreich
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 13(2)
Atrial fibrillation is an abnormal heart rhythm characterized by rapid, disorganized activation (fibrillation) of the left and right atria of the heart, and is responsible for 15% of 700,000 strokes in the United States each year. There are multiple
Autor:
Jeffrey A. Tice, Donald D. Hoang, Paul J. Wang, Mintu P. Turakhia, Leah S. Karliner, Paul A. Heidenreich, Anurag Gupta
Publikováno v:
American heart journal. 163(3)
Background Prior studies have indicated that the magnitude of risk association of microvolt T-wave alternans (MTWA) testing appears to vary with the population studied. We performed a meta-analysis to determine the ability of MTWA to modify risk asse
Autor:
Susan K. Schmitt, Claire T. Than, Donald D. Hoang, Felix Yang, Xiangyan Xu, Mintu P. Turakhia, Ciaran S. Phibbs, Susan M. Frayne, Paul J. Wang, Paul A. Heidenreich
Publikováno v:
American Heart Journal. 165:93-101.e1
Atrial fibrillation and flutter (AF, collectively) cause stroke. We evaluated whether treating specialty influences warfarin prescription in patients with newly diagnosed AF.In the TREAT-AF study, we used Veterans Health Administration health record
Autor:
Paul A. Heidenreich, Uday N. Kumar, Felix Yang, Victor F. Froelicher, Mintu P. Turakhia, Donald D. Hoang, Xiangyan Xu, Peter Zimetbaum, Jared D. Miller
Publikováno v:
The American Journal of Cardiology. (4):520-524
Although extending the duration of ambulatory electrocardiographic monitoring beyond 24 to 48 hours can improve the detection of arrhythmias, lead-based (Holter) monitors might be limited by patient compliance and other factors. We, therefore, evalua